The lack of immunoreactivity for SOX-10 may be useful to exclude a melanocytic neoplasm, but labeling for SOX-10 should not be used as a single criterion for confirmation of a diagnosis of OMM. This evidence concerns the gene SOX10 and melanocytic neoplasm.